Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations |
Stanford University / Ravi Majeti, MD/PhD |
Familial RUNX1 Research Grants |
2016 |
California |
Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models |
Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD |
Familial RUNX1 Research Grants |
2016 |
New York |
Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML |
Boston Children's Hospital / Alan Cantor, MD, PhD |
Familial RUNX1 Research Grants |
2016 |
Massachusetts |
Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish |
Boston Children's Hospital / Leonard Zon, MD |
Familial RUNX1 Research Grants |
2016 |
Massachusetts |
Restoring RUNX1 Levels in FPD/AML |
University of Washington, Seattle / Marshall Horwitz, MD/PhD |
Familial RUNX1 Research Grants |
2016 |
Washington |
Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome |
St. Jude Children's Research Hospital / Lisa Jacola, PhD |
Psychosocial Grants |
2016 |
Tennessee |
The Role of Affective and Cognitive-Executive Processes and Structural Brain Abnormalities on Social Adjustment in Pediatric Brain Tumor Survivors |
University of Calgary / Fiona Schulte, PhD |
Psychosocial Grants |
2016 |
Alberta |
Web-Based Cognitive-Behavioral Treatment for Insomnia in Adolescent Cancer Survivors |
Dana-Farber Cancer Institute / Eric Zhou, PhD |
Psychosocial Grants |
2016 |
Massachusetts |
Enhancing Coping and Communication in Children with Cancer and Their Parents: A Novel Internet-Based Intervention |
Vanderbilt University Medical Center / Bruce Compas, PhD |
Psychosocial Grants |
2016 |
Tennessee |
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children's Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |